Rakha, Emad A.
Hamad Medical Corporation,
Qatar
2025 Rank: 17056
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 501 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17056 | 18176 |
| Total Cites | 2848 | 3147 |
| H-index | 22 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 121 | 121 |
| Total Cites to Single+First Authored Papers | 578 | 634 |
| Number of Single+First+Last Authored Papers | 255 | 255 |
| Total Cites to Single+First+Last Authored Papers | 1122 | 1238 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2406 | 2503 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.26 |
| Self-Citation Percentage |
9.50%
|
|
Rakha, Emad A.
University of Nottingham,
United Kingdom
2024 Rank: 18271
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 589 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18271 | 18089 |
| Total Cites | 2644 | 2940 |
| H-index | 20 | 21 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 120 | 120 |
| Total Cites to Single+First Authored Papers | 564 | 646 |
| Number of Single+First+Last Authored Papers | 242 | 242 |
| Total Cites to Single+First+Last Authored Papers | 956 | 1099 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2272 | 2368 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.24 |
| Self-Citation Percentage |
10.07%
|
|
Rakha, Emad A.
University of Nottingham Medical School,
United Kingdom
2023 Rank: 14986
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 551 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14986 | 12643 |
| Total Cites | 2899 | 3211 |
| H-index | 19 | 21 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 2 | 3 |
| Number of Single+First Authored Papers | 116 | 116 |
| Total Cites to Single+First Authored Papers | 650 | 731 |
| Number of Single+First+Last Authored Papers | 217 | 217 |
| Total Cites to Single+First+Last Authored Papers | 1045 | 1177 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2382 | 2502 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
9.72%
|
|
Rakha, Emad A.
University of Nottingham,
United Kingdom
2022 Rank: 26455
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 975 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26455 | 25528 |
| Total Cites | 2522 | 2834 |
| H-index | 18 | 20 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 110 | 110 |
| Total Cites to Single+First Authored Papers | 519 | 565 |
| Number of Single+First+Last Authored Papers | 192 | 192 |
| Total Cites to Single+First+Last Authored Papers | 838 | 923 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2203 | 2313 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.23 |
| Self-Citation Percentage |
11.01%
|
|
Rakha, Emad A.
University of Nottingham,
United Kingdom
2021 Rank: 18747
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 692 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18747 | 17438 |
| Total Cites | 3602 | 4114 |
| H-index | 22 | 25 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 102 | 102 |
| Total Cites to Single+First Authored Papers | 797 | 879 |
| Number of Single+First+Last Authored Papers | 172 | 172 |
| Total Cites to Single+First+Last Authored Papers | 1211 | 1371 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3088 | 3279 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.25 |
| Self-Citation Percentage |
12.45%
|
|
Rakha, Emad A.
University of Nottingham,
United Kingdom
2020 Rank: 32523
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1145 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32523 | 30261 |
| Total Cites | 2351 | 2699 |
| H-index | 18 | 20 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 101 | 101 |
| Total Cites to Single+First Authored Papers | 600 | 651 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 797 | 906 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2024 | 2163 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.25 |
| Self-Citation Percentage |
12.89%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.